日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma

靶向FAM111B可通过增加MFN2在肝细胞癌中的稳定性来减弱线粒体自噬并提高其对乐伐替尼治疗的敏感性。

Yan, Yu-Chuan; Shao, Li-Juan; Meng, Guang-Xiao; Pan, Guo-Qiang; Li, Rui-Zhe; Xiong, Chen; Liu, Shi-Jia; Ding, Zi-Niu; Zhang, Xiao-Lu; Dong, Xiao-Feng; Qu, Ying; Dong, Zhao-Ru; Li, Tao

Thyroid hormones inhibit tumor progression and enhance the antitumor activity of lenvatinib in hepatocellular carcinoma via reprogramming glucose metabolism.

甲状腺激素通过重编程葡萄糖代谢抑制肿瘤进展,增强乐伐替尼在肝细胞癌中的抗肿瘤活性

Yang Chun-Cheng, Yan Yu-Chuan, Pan Guo-Qiang, Meng Guang-Xiao, Zhang Xiao, Yan Lun-Jie, Ding Zi-Niu, Wang Dong-Xu, Li Rui-Zhe, Li Guang-Zhen, Dong Zhao-Ru, Li Tao

Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis

比较替诺福韦与恩替卡韦在预防慢性乙型肝炎患者肝细胞癌方面的疗效:一项伞状综述和荟萃分析

Liu, Shi-Jia; Zhang, Xiao; Yan, Lun-Jie; Wang, Han-Chao; Ding, Zi-Niu; Liu, Hui; Pan, Guo-Qiang; Han, Cheng-Long; Tian, Bao-Wen; Dong, Zhao-Ru; Wang, Dong-Xu; Yan, Yu-Chuan; Li, Tao

Correction: MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

更正:MALAT1/mir-1-3p介导的BRF2表达通过抑制LKB1/AMPK信号通路促进HCC进展

Li, Guang-Zhen; Meng, Guang-Xiao; Pan, Guo-Qiang; Zhang, Xiao; Yan, Lun-Jie; Li, Rui-Zhe; Ding, Zi-Niu; Tan, Si-Yu; Wang, Dong-Xu; Tian, Bao-Wen; Yan, Yu-Chuan; Dong, Zhao-Ru; Hong, Jian-Guo; Li, Tao

Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis

癌症患者再次使用免疫检查点抑制剂的安全性、有效性和生存结果:系统评价和荟萃分析

Liu, Shi-Jia; Yan, Lun-Jie; Wang, Han-Chao; Ding, Zi-Niu; Liu, Hui; Zhang, Xiao; Pan, Guo-Qiang; Han, Cheng-Long; Tian, Bao-Wen; Yang, Xiao-Rong; Tan, Si-Yu; Dong, Zhao-Ru; Wang, Dong-Xu; Yan, Yu-Chuan; Li, Tao

Is there a place for endoscopic management in post-cholecystectomy iatrogenic bile duct injuries?

胆囊切除术后医源性胆管损伤,内镜治疗是否有一席之地?

Cai, Hong-Qiao; Pan, Guo-Qiang; Luan, Shou-Jing; Wang, Jing; Jiao, Yan

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients

基于脂肪和肌肉相关指标,通过CT图像评估的模型,用于预测肝细胞癌患者的微血管侵犯

Mao, Xin-Cheng; Shi, Shuo; Yan, Lun-Jie; Wang, Han-Chao; Ding, Zi-Niu; Liu, Hui; Pan, Guo-Qiang; Zhang, Xiao; Han, Cheng-Long; Tian, Bao-Wen; Wang, Dong-Xu; Tan, Si-Yu; Dong, Zhao-Ru; Yan, Yu-Chuan; Li, Tao

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

MALAT1/mir-1-3p介导的BRF2表达通过抑制LKB1/AMPK信号通路促进肝细胞癌进展。

Li, Guang-Zhen; Meng, Guang-Xiao; Pan, Guo-Qiang; Zhang, Xiao; Yan, Lun-Jie; Li, Rui-Zhe; Ding, Zi-Niu; Tan, Si-Yu; Wang, Dong-Xu; Tian, Bao-Wen; Yan, Yu-Chuan; Dong, Zhao-Ru; Hong, Jian-Guo; Li, Tao

The relationship between the serum lipid profile and hepatocellular carcinoma in east Asian population: A mendelian randomization study

东亚人群血脂谱与肝细胞癌的关系:一项孟德尔随机化研究

Pan, Guo-Qiang; Jiao, Yan; Meng, Guang-Xiao; Dong, Zhao-Ru; Li, Tao

The causal relationship between white blood cell counts and hepatocellular carcinoma: a Mendelian randomization study

白细胞计数与肝细胞癌的因果关系:一项孟德尔随机化研究

Pan, Guo-Qiang; Yang, Chun-Cheng; Shang, Xiao-Ling; Dong, Zhao-Ru; Li, Tao